Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Henry Schein One has acquired an 80% stake in Jarvis Analytics, a company developing data analytics tools for dental practices. This partnership aims to enhance decision-making and business performance for dental teams by utilizing data from various management systems. The financial impact from Jarvis Analytics is expected to be neutral to Henry Schein's earnings in 2021 but accretive thereafter. Stanley M. Bergman commented on the commitment to tech advancements, while Jarvis Analytics remains agnostic to practice management systems, expanding integration with Henry Schein's offerings.
Summary not available.
Henry Schein, the largest health care solutions provider for dental and medical practitioners, will present at four investor conferences in June 2021. The schedule includes:
- Stifel 2021 Annual Dental & Veterinary Conference on June 2 at 2:00 p.m. ET.
- Jefferies 2021 Virtual Healthcare Conference on June 3 at 2:00 p.m. ET.
- Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 at 1:20 p.m. ET.
- Baird Healthcare ESG Symposium on June 17 at 1:20 p.m. ET.
Live webcasts for the first three conferences are available on their website, with replays following the presentations.
Henry Schein, Inc. (Nasdaq: HSIC) has elected Reed V. Tuckson, M.D., FACP, to its Board of Directors. Dr. Tuckson brings over 35 years of healthcare leadership, having previously served as Executive Vice President at UnitedHealth Group. He is known for his work with the Black Coalition Against COVID-19 and several advisory committees. Stanley M. Bergman, CEO, expressed confidence in Dr. Tuckson's ability to drive health equity and innovation. With this addition, HSIC aims to enhance its commitment to a socially responsible future and address disparities in health access.
Henry Schein (Nasdaq: HSIC) has authorized a share repurchase program worth $400 million, complementing the remaining $33 million from a previous buyback initiated in October 2019. This new program represents approximately 4.0 percent of its 140 million outstanding shares. Executive VP Steven Paladino emphasized that this decision demonstrates the company's commitment to strategic priorities and solid cash flow generation, allowing for a balanced capital allocation strategy that supports growth and acquisitions.
Summary not available.
Henry Schein One has launched a new software module named Consistency of Care designed to integrate dental and medical patient records. This initiative responds to the increased demand from health care providers for comprehensive patient services. Developed by Exan Software, the module enhances interoperability, allowing dental schools to share patient records with medical schools. Penn Dental Medicine is the first to adopt this module. The integration aims to improve patient care, ensure accurate health records, and streamline data management, thereby enhancing overall patient outcomes and efficiency.
Henry Schein reported record Q1 financial results with total net sales of $2.9 billion, a 20.4% increase year-over-year. This surge was driven by 14.9% internal growth in local currencies, alongside contributions from acquisitions and foreign currency exchange. GAAP net income rose to $166 million ($1.16 per diluted share), up from $130.5 million ($0.91 per diluted share) in Q1 2020. The company also raised its 2021 non-GAAP EPS guidance to at least $3.70. Despite challenges from the pandemic, Henry Schein's performance reflects strong operational execution.
Henry Schein (Nasdaq: HSIC), a leading health care solutions provider, will present at the Bank of America Securities 2021 Virtual Health Care Conference on May 11, 2021, at 10:15 a.m. ET. The presentation will be accessible via live webcast on the company's website, with a replay available afterward. Henry Schein serves over 1 million customers globally, offering more than 300 solutions that enhance operational efficiency and clinical outcomes for dental and medical practitioners. In 2020, the company reported sales of $10.1 billion, demonstrating significant growth since its public debut in 1995.
Henry Schein's CEO, Stanley M. Bergman, urged the House Select Subcommittee on the Coronavirus Crisis to include primary care physicians and dentists in the national COVID-19 vaccination effort. He emphasized their importance in addressing vaccine hesitancy and their unique access across diverse communities. The letter was part of a hearing that included expert testimonies from public health leaders. Henry Schein, a Fortune 500 company, supports healthcare professionals with technology and solutions, generating $10.1 billion in sales in 2020.